HTG2014-Section-Header-publications

Categories

Filter by Topics

AACR2023 ADCC Gene Alteration adolescents ALK Angiogenesis Apoptosis Autocrine Signaling B-accute lyphoblastic seukemia B-ALL Biology of neoplasia Biomarkers Bladder Cancer Blastic plasmacytoid dandritic cell neoplasm BPDCN Blood bone Brain Breast Cancer CAR T cell therapy Cardiovascular Disease CDKN2A mutation Cell Free Plasma Cells Chemokines Circulating miRNAs clinical trial Colorectal cancer Comparison study Core Needle Biopsy COVID-19 Custom mRNA Cytokines Developmental Immunotherapy Developmental Therapeutics Diabetes Differential Expression Differential Gene Expression Analysis DLBCL Drug Response Drug sensitivity Efficacy EHE cancer EMT Epstein-Barr ERBB3 Esophageal Cancer estrogen and progesteron receptors Exosomes extracellular miRNAs Extracellular Vesicles Feasibility FFPE FGF Ligand Trap FGFR Follicular lymphoma Gene Expression Gene Expression Profiling Gene Fusions Gene Signature Analysis Genetic Polymorphism Genitourinary cancer Glioblastoma Tumors Head and Neck Cancer Heart HER-2 HER2- HLA-E Homing HPV HR+ HTG EdgeSeq ALKPlus Assay EU HTG EdgeSeq DLBCL Cell of Origin Assay HTG EdgeSeq DLBCL Cell of Origin Assay EU HTG EdgeSeq EGFR KRAS and BRAF Mutation Assay HTG EdgeSeq Immune Response Panel HTG EdgeSeq Immuno-Oncology Assay HTG EdgeSeq Immuno-Oncology Panel HTG EdgeSeq Lung Fusion Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq miRNA Whole Transcriptome Panel HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq PATH Assay HTG EdgeSeq Precision Immuno-Oncology Panel HTG EdgeSeq System Immune Cells Immune Checkpoint Inhibitors Immune Response Immune System Immuno-Oncology Immunotherapy Integrins IOA- 244 IRP Kidney LAG3+ Liposarcoma Liquid Biopsy liver Liver liver tissue Lung lungs Lupus Lymphocytes Lymphoma lymphoma Melanoma melanoma Mesothelioma Microenvironment miRNA miRNA WTA Molecular Characterization Mouse mRNA custom mTOR signaling Multiple Myeloma MYC Natural Killer Cells Neoantigens Novel Therapeutic Targets OBP Oral Cancer Oral cancer oral squamous cell carcinoma OSCC Osteoarthritis palbociclib PALLET PALOMA PALOMA-2 PanB Pancreas Pathway Analysis Patient Stratification PAXgene PBMCs PCA Cell Lines PD-L1 PDX model PENELOPE-B PFAS PI3K inhibitors PIK3CA mutation PIP Plasma Platform Comparison Programmed cell death protein 1 Prostate Prostate Cancer qNPA qPCR Rbsig Renal Cell Carcinoma Reproductive Reveal Rheumatoid Arthritis safety Sarcoma Serum Signaling Inhibitors Signaling Pathways Signature Validation Signatures Sinonasal Carcinoma Squamous cell carcinoma STAT6 pathway Sub-typing Testicular cancer Therapeutic Response TMB Toxicity TP53 mutation Transplantation Treatment Outcome Treatment Stratification Triple Negative Breast CancerTNBC Tumor Biology Tumor Immunobiology Tumor infiltrating lymphocytes Tumor Microenvironment tumor microenvironment Urine Urothelial carcinoma VEGFR Xenograft Tissue

2013

Array-based Quantitative Nuclease Protection Assay Can Reproducibly Identify Prognostic mRNA Biomarkers in Archival Mantle Cell Lymphoma Specimens

Yang D., et al. Array-based Quantitative Nuclease Protection Assay Can Reproducibly Identify Prognostic mRNA Biomarkers in Archival Mantle Cell Lymphoma Specimens. Mod Pathol. 2013 Feb;26(S2):368A.

Download pdf 1.0MB

Investigation of a Redox-Sensitive Predictive Model of Mouse Embryonic Stem Cell Differentiation via Quantitative Nuclease Protection Assays and Gluthione Redox Status

Chandler K., et al. Investigation of a Redox-Sensitive Predictive Model of Mouse Embryonic Stem Cell Differentiation via Quantitative Nuclease Protection Assays and Gluthione Redox Status. Poster session presented at: 52nd Annual Society of Toxicology Meeting; 2013 Mar 10-14, San Antonio, TX.

View External Link

Automated Measurement of Gene Expression from FFPE: qNPA vs. qPCR

Rounseville M., et al. Automated Measurement of Gene Expression from FFPE: qNPA vs. qPCR. Poster session presented at: Molecular Med Tri-Con; 2013 Feb 11-15; San Francisco, CA

Download pdf 830KB

2012

Measuring molecular biomarkers in epidemiologic studies: laboratory techniques and biospecimen considerations

Erickson H.S. Measuring molecular biomarkers in epidemiologic studies: laboratory techniques and biospecimen considerations. Stat Med. 2012 Sep 28;31(22):2400-13.

PMID: 22593027

View External Link

miRNA profiling for biomarker discover in multiple sclerosis: From microarray to deep sequencing

Guerau-de-Arellano M., et al. miRNA profiling for biomarker discover in multiple sclerosis: From microarray to deep sequencing. J Neuroimmunol. 2012 Jul 15; 248(1-2):32-39.

PMID: 22078708

View External Link

Effects of β4 integrin expression on microRNA patterns in breast cancer

Gerson K., et al. Effects of β4 integrin expression on microRNA patterns in breast cancer. Biol Open. 2012 Jul 15; 1(7):658-666.

PMID: 23213459

View External Link

Discovery and Structure-Activity Relationship Studies of Indole Derivatives as Liver X Receptor (LXR) Agonists

Bakir F., et al. Discovery and Structure-Activity Relationship Studies of Indole Derivatives as Liver X Receptor (LXR) Agonists. Bioorg Med Chem Lett. 2007 Jun 15;17(12): 3473–3479.

PMID: 17416521

View External Link

2011

Quantitative Nuclease Protection Assay (qNPA) for Gene Expression Analysis on Brest Cancer Core Biopsies.

Evangelist M., et al. Quantitative Nuclease Protection Assay (qNPA) for Gene Expression Analysis on Brest Cancer Core Biopsies. J Clin Oncol. 2011 Sep 20;29(Suppl 27);abstr 49.

View External Link

A High-Density Quantitative Nuclease Protection Microarray Platform For High Throughput Analysis of Gene Expression.

Bourzac K., et al. A High-Density Quantitative Nuclease Protection Microarray Platform For High Throughput Analysis of Gene Expression. J Biotechnol. 2011 Jun 10;154(1):68-75. 

PMID: 21504771

View External Link

Accurate Classification of Diffuse Large B cell Lymphoma into Germinal Center and Activated B cell Subtypes Using a Nuclease Protection Assay on Paraffin Embedded Tissues.

Rimsza L., et al. Accurate Classification of Diffuse Large B cell Lymphoma into Germinal Center and Activated B cell Subtypes Using a Nuclease Protection Assay on Paraffin Embedded Tissues. Clin Cancer Res. 2011 Jun 1:17(11)

PMID: 21364035

View External Link

Identification of ALK gene alterations in urothelial carcinoma (UC).

Bellmunt, J. Identification of ALK gene alterations in urothelial carcinoma (UC). J Clin Oncol. 2011 Sep 20;29(Suppl 27);abstr 4568. 

View External Link

2010

A Strategy for Full Interrogation of Prognostic Gene Expression Patterns: Exploring the Biology of Diffuse Large B Cell Lymphoma.

Rimsza L, et al. A Strategy for Full Interrogation of Prognostic Gene Expression Patterns: Exploring the Biology of Diffuse Large B Cell Lymphoma. PLoS One. 2011;6(8):e22267.

PMID: 21829609

View External Link

Page last updated May 22, 2023